In consistency with our results, other studies have shown that ATM/RB1 inactivation were associated with poor prognosis in multiple cancer types, such as leukemia, breast cancer, lung cancer, brain tumor and bladder cancer [9–13]. Here, RB1 is linked to brain neoplasm.